These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1693783)

  • 21. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
    Tek I; Arslan O; Arat M; Ozcan M; Akdağ B; Ilhan O
    Transfus Apher Sci; 2003 Feb; 28(1):3-7. PubMed ID: 12620262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange in type II hypercholesterolemia.
    Kamanabroo D; Ulrich K; Gröbe H; Assmann G
    Prog Clin Biol Res; 1988; 255():347-56. PubMed ID: 3340644
    [No Abstract]   [Full Text] [Related]  

  • 23. Is hydroxyethyl starch safe in brain injury?
    Haynes GR
    Anesth Analg; 2004 Aug; 99(2):620; author reply 620-2. PubMed ID: 15271753
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure.
    Tek I; Arslan O; Arat M; Ayyildiz E; Tol M; Oral M; Ilhan O
    Transfus Apher Sci; 2004 Oct; 31(2):89-93. PubMed ID: 15501412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange.
    McLeod BC
    Best Pract Res Clin Haematol; 2006; 19(1):157-67. PubMed ID: 16377548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.
    Haskell LP; Tannenberg AM
    N Y State J Med; 1988 Jul; 88(7):387-8. PubMed ID: 2457189
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternatives to albumin: starch replacement for plasma exchange.
    Brecher ME; Owen HG; Bandarenko N
    J Clin Apher; 1997; 12(3):146-53. PubMed ID: 9365868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All formulations of hydroxyethyl starch are not the same.
    Strauss RG
    Transfusion; 2007 Jul; 47(7):1329-30; author reply 1330-1. PubMed ID: 17581172
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic applications of plasma exchange.
    Savage CO; Banks I; Pusey CD
    Br J Hosp Med; 1988 Oct; 40(4):272-4, 276-9, 282-3. PubMed ID: 2465804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM
    Wien Med Wochenschr; 1994; 144(12-13):333-5. PubMed ID: 8650940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coagulation changes during aortofemoral bifurcation bypass: is volume and plasma substitution possible with hydroxyethyl starch alone?].
    von Sommoggy S; Fraunhofer J; Jelen-Esselborn S; Stemberger A
    Anaesthesist; 1990 Jul; 39(7):353-60. PubMed ID: 1696795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of erythrocyte and lymphocyte membrane fluidity after plasma extraction in children with type II homozygous hypercholesterolemia].
    Motta C; Palcoux JB; Meyer M; Roche M
    Ann Med Interne (Paris); 1988; 139 Suppl 1():83-5. PubMed ID: 3247997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term plasma exchange via Cimino fistula in patients with hypercholesterolemia.
    Passfall J; Keller F; Arntz HR
    Biomater Artif Cells Artif Organs; 1990; 18(5):617-21. PubMed ID: 2099216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of the percent of exchanged plasma in continuous membrane separation and substitution with human albumin].
    Muschmov D; Kirjakov Z; Stantschev I
    Z Urol Nephrol; 1986 Jun; 79(6):325-7. PubMed ID: 3751354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobilisation of tissue cholesterol by apheresis.
    Thompson GR
    Prog Clin Biol Res; 1990; 337():183-7. PubMed ID: 2191311
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What are the established clinical indications for therapeutic plasma exchange and how important is the choice of replacement fluid for efficacy of therapeutic plasma exchange in these situations?
    Vox Sang; 1982 Nov; 43(5):270-95. PubMed ID: 6216664
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of citrate anticoagulation during plasma exchange with different replacement solutions.
    Antonic M; Gubensek J; Buturović-Ponikvar J; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):322-6. PubMed ID: 19695068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.